I’m super excited to launch Corsera Health! This is another collaboration with my friend Clive Meanwell. Our vision: a world without Cardiovascular disease! www.businesswire.com/news/home/20...

www.washingtonpost.com/business/202... Basic research “is almost like the starter when you bake sourdough bread. You can’t make the bread without it.”

“Brain drain” of scientists could have DIRE consequences for US leadership! “Europe, Canada, and China are laying out the red carpet to attract scientists disillusioned by America’s shifting policies.” 🙏 ⁦‪Ashish Jha‬⁩ for this thoughtful piece! www.bostonglobe.com/2025/05/27/o...

SO PROUD of the City Team forming their 2nd major alliance!!!! This time with Biogen for a CNS target, w/ $46M upfront and >$1B in total deal value! Combined with earlier Bausch & Lomb deal, City is growing strong in a tough tape! www.globenewswire.com/news-release...

I’m all for real “MAHA!” Everyone should be! Here are some real ideas from experts. www.statnews.com/2025/05/21/r...

“The report also raises concerns about… children and their prescription drug use, including antibiotics and medications used to treat attention deficit disorders. So, where’s the “gold-standard science” supporting these and other purported concerns? www.bostonglobe.com/2025/05/22/n...

“Proposed funding cuts, the firing of essential federal scientists, and policy uncertainties threaten to undermine the foundation for our nation’s global leadership,” Collins said. I could not agree more!

IMO… Bigger risks to KSQ are: - Capital markets, made worse by uncertainty of destabilized FDA and tariffs - Attack on academic institutions and science - “Hybrid” work, with fewer people interacting in KSQ www.bostonglobe.com/2025/04/14/b...

We must preserve our U.S. leadership in science and medicine! Also supported by economic grounds alone…. “History shows that science reliably generates immense economic benefit.” www.cnn.com/2025/04/09/h...

Some strategy tips for biotech CEOs in this brutal environment from a convo with ⁦‪@AndrewE_Dunn‬⁩ from ⁦‪@endpts‬⁩. My favorite tip (not covered as much in article) is to be hyper focused on what moves the needle for patients, and then investors. endpts.com/biotech-mark...

GO VACCINES! www.nytimes.com/2025/04/02/h...

New company aiming to transform health… Exciting times ahead!

It’s RFK Jr.’s FDA now My take on Peter Marks' ouster -- and why you don't have to think Marks is a hero to be worried about what it means. www.statnews.com/2025/03/31/r...

“I hope Marty comes understanding magnitude of his responsibility and builds back FDA that is based on science and being gold-standard regulatory authority of the world.”

www.statnews.com/2025/03/29/f... Makary has “unprecedented opportunity and enormous responsibility to rebuild FDA.” “never seen this large of a set of openings under one commissioner,”

www.wsj.com/politics/top... “It has become clear that truth and transparency are not desired by the Secretary, but rather he wishes subservient confirmation of his misinformation and lies”

www.nature.com/articles/d41... We must attract and RETAIN the greatest and best scientists in the world if the US is going to be “Great Again!”

Important oped by ⁦‪@DrSidMukherjee‬⁩…. “we seem to be turning away from the idea that health is a collective endeavor, a public good at all, and retreating into the rhetoric of personal responsibility.” Fully share this concern as our public health apparatus is being dismantled!

We lead the world in science and medicine for patients! A big part of this is our vibrant biotechnology industry… But our leadership requires strong and well funded basic research at the @NIH!

Completely avoidable.

Why. We. Do. What. We. Do! Bravo ⁦‪@Regeneron‬⁩!

Same story, 14 years and one day later. For the sake of patients, let’s hope for the same outcome! Keep going, CRISPR folk!

News like this makes my day… - Great clinical data with profound impact for patients in high unmet need indication - Market responds positively rewarding investors A reminder that this is how biotech should work!

So fun to unite with ALumNY at JPM. It’s so important to stay close with former colleagues in next chapters. Sometimes you end up working together again (as is the case with many here)!

This is great! FDA modernization grounded in science and evidence would be welcome!

Terrific way to close out 2024 with a round up of medical advances. Thanks ⁦‪@matthewherper‬⁩! - 50 FDA approvals - Impressive roster of new medicines and data - Despite lingering and tough capital markets, science prevails Happy New Year to all!

My personal favorite: “Vutrisiran in patients with transthyretin mediated cardiomyopathy”!

Found my seat at the airport! 🤣🤣🤣